Tetra, New Brunswick to collaborate on cannabis research

Tetra, New Brunswick to collaborate on cannabis research

Tetra Bio-Pharma (OTCQB:TBPMF; CSE:TBP) and the New Brunswick Health Research Foundation are investing $500,000 each over five years to establish a health research chair in cannabis at the University of New Brunswick.

Read More

Clearside presents positive Phase 2 extension study data

Clearside presents positive Phase 2 extension study data

Clearside Biomedical (NASDAQ:CLSD) presented positive data from an extension study of patients who participated in the completed Phase 2 trial of its suprachoroidal CLS-TA in combination with intravitreal Eylea for the treatment of macular edema associated with retinal vein occlusion (RVO).

Read More

Karen Koski joins Oxford Immunotec as head of strategy

Karen Koski joins Oxford Immunotec as head of strategy

Oxford Immunotec Global (NASDAQ:OXFD) has appointed Karen Koski as head of strategy and investor relations, a newly created position that will report directly to CEO, Peter Wrighton-Smith. The appointment is effective on June 21.

Read More